Please assess the completion status of the following clinical trial:

Trial Title: The Efficacy of Peritubal Analgesic Infiltration in Postoperative Pain Following Percutaneous Nephrolithotomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18-70 years of age~* body mass index \<35,~* renal stone size \>2.0 cm.~Exclusion Criteria:~* patients having supra-costal puncture.~* excessive intraoperative bleeding.~* renal stones requiring more than a single puncture.~* surgical procedure extending more than 3 hours.~* urinary tract infection.~* severe cardiopulmonary disease.~* abnormal renal function tests.~* allergy to local anesthetics.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- study group :infiltration with 0.25% bupivacaine post-op (Type: ACTIVE_COMPARATOR): At the end of the procedure ( surgery), In the patients of the study group, the 23-gauge, 90mm spinal needle will inserted up to the renal capsule under fluoroscopic guidance along the nephrostomy tube at 6 and 12 o'clock positions (cranial and caudal); then 20 ml of 0.25% bupivacaine will infiltrated into the nephrostomy tract, while gradually withdrawing the needle from renal capsule to the skin thereby infiltrating the renal capsule, perinephric fat, muscles, subcutaneous tissue and skin
- control group , no anesthesia infiltration post-op (Type: NO_INTERVENTION): control group: no anesthesia infiltration had been given post opertatively

Based on this trial design, predict the completion outcome and termination type (if applicable).